top of page
Writer's pictureAbderrahim Benmoussa, phD

On Ibuprofen-associated risk during COVID-19, a news story

Updated: Apr 6, 2020

Quality of evidence: C-

 

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists

 

Authors: Michael Day

Journal: The British Medical Journal

Objectives: Report the latest news on the opinions of the experts on the use of ibuprofen during COVID-19

Strength of evidence: Low (news feed, recommendations based on low count of cases

Methods/publication type: Summary of expert opinions, letter to the editor and case reports

Highlights :

  • NSAIDs might increase the duration of the infection, limit the immune response and possibly increase symptoms

  • However, they might be useful in limiting IL-6 and cytokine-storm

  • There is a very little counter indication for not using NSAIDs out of precaution as there are other drugs

  • Recommendation not to use NSAIDs for symptomatic treatment

  • Favor paracetamol (Tylenol) instead

 

4 views0 comments

Recent Posts

See All

Comments


bottom of page